Glen Harbor Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$339K Sell
9,240
-84
-0.9% -$3.33K 0.01% 842
2019
Q2
$434K Sell
9,324
-2,436
-21% -$114K 0.01% 748
2019
Q1
$472K Buy
11,760
+364
+3% +$16.3K 0.01% 698
2018
Q4
$524K Sell
11,396
-2,324
-17% -$112K 0.01% 599
2018
Q3
$609K Buy
13,720
+11,900
+654% +$546K 0.01% 639
2018
Q2
$71K Sell
1,820
-15,848
-90% -$801K ﹤0.01% 1182
2018
Q1
$1.28M Buy
17,668
+13,384
+312% +$983K 0.03% 364
2017
Q4
$282K Sell
4,284
-3,108
-42% -$167K 0.01% 857
2017
Q3
$371K Sell
7,392
-896
-11% -$43.2K 0.01% 690
2017
Q2
$384K Sell
8,288
-2,800
-25% -$103K 0.01% 667
2017
Q1
$391K Hold
11,088
0.01% 617
2016
Q4
$139K Buy
+11,088
New +$132K ﹤0.01% 800

Other funds holding ESPR